Natural supplement shows promise for fatty liver
NCT ID NCT06697977
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested whether taking phytosterols (plant-based supplements) for 3 months can improve liver health, cholesterol, and insulin levels in people with nonalcoholic fatty liver disease (NAFLD). 27 participants took either phytosterol pills or a placebo. Researchers measured liver enzymes, blood fats, and other markers to see if the supplement helps manage the condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- phytosterols (plant-based supplements)
- What this could lead to
- If it works, this could point toward a simple, natural supplement to help manage fatty liver disease and related health issues.
- What could go wrong
- This was a small, early study with only 27 participants. Results may not apply to everyone, and supplements are not a substitute for medical treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
27 people
The number who actually took part.
- Started
-
Aug 2023
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * any patient with NAFLD or NASH that has been diagnosed by any type of imaging. * ability to swallow pills. * ability to take the supplement for 3 months. Exclusion Criteria: * history of liver transplantation. * tested positive for any type of hepatitis. * diagnosed with autoimmune hepatitis. * significant alcohol consumption. * current corticosteroids or antibiotics consumption. * rapid unintentional weight loss. * diagnosed with heart failure. * diagnosed with renal disease. * pregnant and lactating women. * patients with a BMI higher than 40. * patients who are consuming other supplements within the last three months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Jordan
Amman, Jordan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Heartbeat test aims to catch hidden nerve damage in diabetes
- Can Home-Delivered meals help control diabetes?
- Which exercise dose best helps kids with metabolic syndrome?
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test